Back to search
Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Polyarticular Course Juvenile Idiopathic Arthritis (JIA) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Polyarticular Course Juvenile Idiopathic Arthritis (JIA) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a multicenter Phase 3, open-label, single-arm study to evaluate the safety, tolerability, PK, and efficacy of orally administered filgotinib for up to 1…
This study is an open-label, randomized, multicenter trial that incorporates a multi-arm design comparing each of 3 non-TNFi (Tumor Necrosis Factor inhibitor) m…
The purpose of this study is to evaluate the pharmacokinetics (the study of the way a drug enters and leaves the blood and tissues over time) of golimumab admin…
This long-term, open-label extension study will evaluate the safety of RoActemra/Actemra (tocilizumab) in patients with polyarticular-course juvenile idiopathic…